Key Insights

Highlights

Treatment Research

1 treatments under study, led by Thrombolysis Therapy

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05454787Recruiting

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

NCT06878066Phase 3Recruiting

Thrombolysis in Factor Xa-inhibitors Trial

Showing all 2 trials

Research Network

Common Treatments

  • Thrombolysis Therapy1

Active Sponsors

  • Klinbeforsk1
  • AstraZeneca1
  • Clinical Trial Unit (CTU), Oslo University Hospital1
  • Guri Hagberg1

Top Investigators

Related Conditions

  • Anticoagulant Therapy1
  • Ischemic Stroke1
  • Stroke1
  • Hemorrhagic Transformation Due To Acute Stroke1
  • Stroke In Patients With Atrial Fibrillation1

Activity Timeline